Active ingredientOxaprozinCat. No. P-O050-001CAS 21256-18-8Family · Pharmaceutical analytical standards
Oxaprozin
A non-steroidal anti-inflammatory drug derived from propionic acid, patented in 1967 and approved for medical use in the 1980s (in the United States in 1992): it relieves pain, swelling and stiffness in osteoarthritis and rheumatoid arthritis. This family brings together the active ingredient, metabolites, labelled standards and other impurities.
Did you know?Its half-life is about 55 hours, more than two days, and in the blood 99% of it is bound to plasma proteins.
Go to the active ingredient →Active ingredientOxaprozinCat. No. P-O050-001CAS 21256-18-8
MetaboliteOxaprozin Acyl GlucuronideCat. No. P-O050-002CAS 90283-09-3
Isotopically labelledOxaprozin-d5Cat. No. P-O050-003CAS 2933758-40-6
ImpurityOxaprozin Impurity 1Cat. No. P-O050-004CAS 55217-15-7
Impurity3-(4,5-diphenyloxazol-2-yl)propanamideCat. No. P-O050-005CAS 24248-49-5
ImpurityOxaprozin Impurity 2Cat. No. P-O050-006CAS 55217-14-6No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.